Feb 28 (Reuters) - AB Science SA ABS.PA :
* FINANCING OF 8.5 MILLION DOLLARS THROUGH ISSUANCE OF
CONVERTIBLE
BONDS WITH ATTACHED WARRANTS (WITH A CONVERSION PRICE OF EUR
14.0)
* 50,000 OCABSA WILL BE ISSUED, REPRESENTING A NOMINAL VALUE
OF
USD 8.5 MILLION
* IT WILL REINFORCE CASH POSITION OF AB SCIENCE FOR
DEVELOPMENT OF
ITS CLINICAL RESEARCH PROGRAM
* SETTLEMENT DELIVERY OF OCABSA WILL HAPPEN AT LATEST ON
MARCH 7,
2022
* ISSUANCE OF OCABSA, CONVERSION OF OCA INTO ORDINARY SHARES
OF AB
SCIENCE AND EXERCISE OF WARRANTS, AS CASE MAY BE, WILL NOT BE
SUBJECT TO ANY PROSPECTUS TO BE FILED WITH FRENCH AUTORITÉ DES
MARCHÉS FINANCIERS
* WARRANTS WILL NOT BE LISTED ON EURONEXT PARIS
* WARRANTS WILL BE FREELY TRADABLE AND WILL BE EXERCISABLE
FROM
THEIR ISSUANCE UNTIL DECEMBER 31, 2030
* WARRANTS NOT EXERCISED AT END OF EXERCISE PERIOD WILL BE
NULL
AND VOID
* WARRANT WILL GIVE RIGHT TO ITS HOLDER, DURING EXERCISE
PERIOD,
TO SUBSCRIBE TO ONE ORDINARY SHARE OF AB SCIENCE
* SUBSCRIPTION PRICE OF ONE ORDINARY SHARE UPON EXERCISE OF
A
WARRANT WILL BE EQUAL TO 12.65 EUROS.
* OCA WILL BE FREELY TRADABLE
* OCA THAT WILL NOT BE CONVERTED BEFORE MATURITY DATE WILL
BE
REDEEMED BY AB SCIENCE AT THEIR PAR VALUE
Source text for Eikon: ID:nGNE1tbMPn
Further company coverage: ABS.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))